Multidisciplinary Research Training to Understand and Reduce HIV Incidence in Uganda

多学科研究培训以了解和减少乌干达的艾滋病毒发病率

基本信息

  • 批准号:
    10341059
  • 负责人:
  • 金额:
    $ 29.54万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-05-10 至 2024-01-31
  • 项目状态:
    已结题

项目摘要

While substantial progress have been made in the global HIV response, impact have been uneven. Uganda provides a prime case study. Uganda was an early epicenter of the epidemic, with the first report of “slim disease” in East Africa published by our group in 1985. Over the next two decades, Uganda was a leader in efforts to control the epidemic. More recently, new HIV infections remain substantial, particularly in hard-to- reach subpopulations, and the modern Ugandan response to the HIV epidemic presents an improving but mixed picture. Despite moderate scale-up of HIV services, it is estimated that there are still approximately 28,000 yearly AIDS-related deaths and 83,000 new infections in the setting of suboptimal antiretroviral therapy and male circumcision coverage. High mobility, suboptimal linkage and retention in care, persistent high risky sexual behaviors, and an incomplete understanding of HIV transmission dynamics continue to compromise an optimal response. Adding to these challenges are the increasing identification of HIV “hotspots” in Uganda, geographic areas of high HIV burden, where HIV services are often limited. Uganda, like most PEPFAR countries, has adopted more aggressive approaches, including Test and Treat All and introducing Pre- Exposure Prophylaxis (PrEP). However, the impact of these approaches is unclear and will need close monitoring to understand their implementation and impact. This complexities of HIV transmission dynamics and responses raise many critical research questions which impact both Ugandan and Sub-Saharan African policies and programs. In order to address these research areas, it is essential that local capacity be strengthened. In particular, we believe capacity must be built in a multidisciplinary fashion to better understand and reduce HIV incidence in Uganda and beyond, a high priority NIH research area. Our group has a long and successful legacy of training leaders in HIV research and are strongly positioned to build upon this foundation. We propose a multidisciplinary approach to developing scientific capacity in Uganda which will emphasize 3 synergistic areas: (1) Implementation Science, (2) Geospatial Analysis/Infectious Disease Dynamics and (3) Virology/Immunology/HIV Cure. These disciplines span the clinic, community, modeling, and the lab sciences and will ensure that we reach the long-term goals and objectives of the program, which are that Ugandan institutions will have the research capacity needed to understand, respond to, and eventually control the HIV epidemic. We will involve 22 trainees in multidisciplinary bachelor, master's, PhD, and post- graduate level training, mostly in Uganda. The primary beneficiaries of this training will be the Rakai Health Sciences Program and the Makerere University School of Public Health in Uganda with whom Johns Hopkins University, the applicant institution, has had a highly successful collaborative relationship for 30 years. Our anticipated outcome is to have developed a world-class cadre of Ugandan research capacity capable of leading Uganda to the end of its HIV epidemic.
虽然全球艾滋病毒防治工作取得了重大进展,但影响参差不齐。乌干达

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Results of Early Virologic Monitoring May Facilitate Differentiated Care Monitoring Strategies for Clients on ART, Rakai, Uganda.
早期病毒学监测结果可能有助于为 ART 客户制定差异化护理监测策略,乌干达拉凯。
  • DOI:
    10.1093/ofid/ofy212
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    4.2
  • 作者:
    Ssempijja,Victor;Chang,LarryW;Nakigozi,Gertrude;Ndyanabo,Anthony;Quinn,ThomasC;Cobelens,Frank;Wawer,Maria;Gray,Ronald;Serwadda,David;Reynolds,StevenJ
  • 通讯作者:
    Reynolds,StevenJ
Effectiveness of intensive adherence counselling in achieving an undetectable viral load among people on antiretroviral therapy with low-level viraemia in Uganda.
在乌干达接受抗逆转录病毒治疗的低水平病毒血症人群中,强化依从性咨询对于实现不可检测的病毒载量的有效性。
  • DOI:
    10.1111/hiv.13568
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    3
  • 作者:
    Nanyeenya,Nicholus;Nakanjako,Damalie;Makumbi,Fredrick;Nakigozi,Gertrude;Nalugoda,Fred;Kigozi,Godfrey;Nasuuna,Esther;Kibira,SimonPS;Nabadda,Susan;Kiyaga,Charles;Huzaifah,Mutyaba;Kiwanuka,Noah
  • 通讯作者:
    Kiwanuka,Noah
Adaptive Viral Load Monitoring Frequency to Facilitate Differentiated Care: A Modeling Study From Rakai, Uganda.
自适应病毒载量监测频率以促进差异化护理:乌干达拉凯的一项建模研究。
Enhancers and barriers to uptake of male circumcision services in Northern Uganda: a qualitative study.
  • DOI:
    10.1080/09540121.2019.1698703
  • 发表时间:
    2020-08
  • 期刊:
  • 影响因子:
    1.7
  • 作者:
    Nanteza BM;Makumbi FE;Gray RH;Serwadda D;Yeh PT;Kennedy CE
  • 通讯作者:
    Kennedy CE
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Larry William Chang其他文献

Larry William Chang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Larry William Chang', 18)}}的其他基金

Epidemiology and Impact of the HIV, NCD, and Urbanization Syndemic in Africa
非洲艾滋病毒、非传染性疾病和城市化综合症的流行病学及其影响
  • 批准号:
    10540800
  • 财政年份:
    2021
  • 资助金额:
    $ 29.54万
  • 项目类别:
Epidemiology and Impact of the HIV, NCD, and Urbanization Syndemic in Africa
非洲艾滋病毒、非传染性疾病和城市化综合症的流行病学及其影响
  • 批准号:
    10159610
  • 财政年份:
    2021
  • 资助金额:
    $ 29.54万
  • 项目类别:
Epidemiology and Impact of the HIV, NCD, and Urbanization Syndemic in Africa
非洲艾滋病毒、非传染性疾病和城市化综合症的流行病学及其影响
  • 批准号:
    10338192
  • 财政年份:
    2021
  • 资助金额:
    $ 29.54万
  • 项目类别:
Hard-to-Reach Populations: Implications for Ending the AIDS Epidemic
难以接触的人群:对结束艾滋病流行的影响
  • 批准号:
    10385844
  • 财政年份:
    2019
  • 资助金额:
    $ 29.54万
  • 项目类别:
Hard-to-Reach Populations: Implications for Ending the AIDS Epidemic
难以接触的人群:对结束艾滋病流行的影响
  • 批准号:
    9920670
  • 财政年份:
    2019
  • 资助金额:
    $ 29.54万
  • 项目类别:
Multidisciplinary Research Training to Understand and Reduce HIV Incidence in Uganda
多学科研究培训以了解和减少乌干达的艾滋病毒发病率
  • 批准号:
    9903488
  • 财政年份:
    2018
  • 资助金额:
    $ 29.54万
  • 项目类别:
RCT to reduce HIV acquisition and viral load among migrants, Rakai, Uganda
旨在减少乌干达拉凯移民中艾滋病毒感染和病毒载量的随机对照试验
  • 批准号:
    9622447
  • 财政年份:
    2018
  • 资助金额:
    $ 29.54万
  • 项目类别:
RCT to reduce HIV acquisition and viral load among migrants, Rakai, Uganda
旨在减少乌干达拉凯移民中艾滋病毒感染和病毒载量的随机对照试验
  • 批准号:
    10408017
  • 财政年份:
    2018
  • 资助金额:
    $ 29.54万
  • 项目类别:
RCT to reduce HIV acquisition and viral load among migrants, Rakai, Uganda
旨在减少乌干达拉凯移民中艾滋病毒感染和病毒载量的随机对照试验
  • 批准号:
    9753373
  • 财政年份:
    2018
  • 资助金额:
    $ 29.54万
  • 项目类别:
Multidisciplinary Research Training to Understand and Reduce HIV Incidence in Uganda
多学科研究培训以了解和减少乌干达的艾滋病毒发病率
  • 批准号:
    10462080
  • 财政年份:
    2018
  • 资助金额:
    $ 29.54万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 29.54万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 29.54万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.54万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.54万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 29.54万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.54万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 29.54万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 29.54万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 29.54万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.54万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了